Erlotinib-Induced Hair Alterations  

Oleh:

Gerber, Peter Arne ; homey, Bernhard

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 358 no. 11 (Mar. 2008), page 1175.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

A 55-year-old woman with metastatic lung cancer was treated with erlotinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor. Cutaneous toxic effects are specific to this class of agents and are associated with an improved clinical outcome. One week after the initial administration of erlotinib, a characteristic facial papulopustular eruption developed, sparing the orbital region. Three months later, typical hair alterations developed (Panels A and B). The brows and lashes darkened and displayed increased thickness (trichomegaly), curling, and elongation, accompanied by increased hair fragility (trichorrhexis). After the initial response to treatment, the patient had progression of the tumor, . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali